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Introduction
Adjuvant radiotherapy (RT) is used to reduce the risk of loco-regional recurrence in women with breast cancer (1, 2) . Patients undergoing RT often experience multiple distressing symptoms including pain, fatigue, heightened stress, and sleep disturbance, with reported occurrence rates of over 60% near the end of RT (3) (4) (5) . Although these symptoms may appear as inevitable, short-term side effects of RT, a significant proportion of patients with breast cancer continue to experience them long after treatment completion (6) (7) (8) . These symptoms have been associated with poorer quality of life (9) . Their high prevalence and tendency to co-occur warrant intervention (10) . Because of their multiple causes and concerns over interactions with concurrent RT, symptom treatment during active RT is a challenging task.
A large volume of research has investigated the use of non-pharmacological interventions to alleviate treatment-related symptoms in cancer patients. Research evidence supports the use of physical movement to relieve fatigue (11) and psychotherapy for pain control (12) , with the latter encompassing a wide range of therapies including cognitive therapy, behavioral therapy, and hypnosis. However, multiple remedies for various symptoms may necessitate frequent travel entailed by daily RT treatment and add to the patients' burden. An integrated intervention with combined elements of movement and psychotherapy could be more effective. Yet, research in this area is relatively scarce.
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Dance movement therapy (DMT) is a movement-based psychosocial intervention that incorporates the therapeutic components of dance movement and group psychotherapy (13) . As defined by the American Dance Therapy Association, DMT uses guided and self-initiated movements to further the emotional, cognitive, physical and social integration of the individual (14) . DMT emphasizes the interconnection between the body and mind such that one can express his mind through body movements (15) . It enables the patients to enhance self-expression, accept and reconnect with their bodies, cope with feelings of depression and fear, rebuild self-confidence, and to strengthen personal resources (16) . The group approach allows them to share their emotions, concerns, and coping strategies with others who are undergoing similar experiences and establish mutual social support (17) .
Previous research studies have reported positive results on the use of DMT on cancer patients (17) (18) (19) (20) (21) . The majority of these studies are, however, not randomized controlled trials (RCT) and only have small sample size with relatively low statistical power. Bradt and colleagues (16) recently reviewed two RCT studies on the therapeutic effects of DMT on cancer patients. Their Cochrane review suggests DMT to have a beneficial effect on quality of life, somatization, and vigor but not on anxiety, depression, fatigue, stress, and body image. It remains unclear whether these findings are due to ineffectiveness of the treatment, unsuitable outcome measures, or limited number of RCT studies. To our knowledge, the effects of DMT on M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 6 patients receiving active cancer treatment have yet to be studied. More RCT studies are needed to elucidate the effects of DMT on physical and psychological outcomes in cancer patients.
The current study aims to explore the changes in treatment-related symptoms (fatigue, anxiety, depression, pain, perceived stress, and sleep disturbance) and quality of life in a sample of Chinese patients with breast cancer during the course of RT. We have reported the qualitative outcomes of the study elsewhere (22) , where DMT was found to provide benefits in terms of coping with cancer, treatment, and physical symptoms and improving mental well-being, attention, and appreciation for the self and body. In this quantitative analysis, we investigate the effectiveness of DMT in symptoms relief in patients with breast cancer . Previous research showed that fatigue or pain levels typically increase during RT, but their patterns over treatment vary by studies (23) . It was hypothesized that a brief DMT intervention over the course of RT would benefit the patients by buffering their treatment-related symptoms while the symptoms would worsen in women who did not receive DMT.
Methods
Study Design
This was a randomized controlled single-blind trial. Simple randomization was carried out with computer generated random numbers to randomize participants into either intervention (DMT) group or waitlist control group. Allocation concealment was carried out by research The flow of the study is presented in Fig. 1 . A total of 317 eligible women were referred by the oncologists or medical social workers at the recruitment sites and subsequently contacted by a research assistant. Each potential participant received an invitation letter with details of the study. A hundred and seventy women declined to participate, mostly due to a lack of time or other personal reasons (response rate of 46%). Eight women withdrew after randomization (5% drop-out) due to personal reasons such as tight schedule, having previous engagement, not being able to commit to data collection etc., leaving 69 participants in the DMT group and 70 in the waitlist control group (total n = 139) for the analysis.
Intervention
The DMT program used for this study originated from the West and was modified by the first author to suit the Chinese culture, which values modesty, emotional control, and respect for
authority. It has been used in local populations with good outcomes and acceptance (17, 25) . The program consisted of six 1.5-hour DMT sessions held twice a week for three consecutive weeks over the course of RT. The program was specially tailored to meet the needs of patients with breast cancer, including stretching, relaxation exercises, movement games and rhythmic body movement to exercise the upper extremities, improvisational dance and movement to explore positive emotions. Interactions, emotional expressions and communications were encouraged among the group members in the sessions. Simple group dances and group sharing were carried out to relate the movement process to participants' personal experiences of breast cancer and cancer treatment. The sessions took place in the hospital, the community cancer support center, and the University of Hong Kong. Each group comprised 6-10 women, and women in the same groups went through the six sessions together. All sessions were led by a qualified dance movement therapist. The waitlist control group did not participate in the intervention program but received radiotherapy and standard nursing care in the hospitals.
Data Collection
Outcome data were collected via self-administered questionnaires before the start of the DMT program (pre-RT) and at 3-week follow up upon the completion of the program (end-RT).
The self-report questionnaires were completed at home and returned to the research team by post.
The self-report questionnaire included validated measurement scales on the following outcomes:
perceived stress, anxiety, depression, fatigue, pain, sleep disturbance, and quality of life. Clinical and demographic data were also collected at pre-RT. In the DMT group, over 90% of the participants attended five or more sessions. In addition, in the last DMT session, qualitative feedback was sought from the participants on whether and how the program helped them during the RT. Over 93% of the participants provided data at end-RT, with attrition rates of 4.3% and 8.6% for the treatment and control groups, respectively.
Outcome Measures
The Perceived Stress Scale is a 10-item, 5-point measurement scale that measures respondents' subjective global experience of stress (26) . The total score ranges from 0 to 40 and higher scores indicate higher levels of perceived stress. The Hospital Anxiety and Depression Scale is a 14-item, 4-point scale used to measure depression and anxiety symptoms (27) . The total scores for anxiety (7 items) and depression (7 items) range from 0 to 21, with higher scores indicating worse mental health status. The Brief Fatigue Inventory is a 9-item, 11-point assessment scale of fatigue severity and its interference with daily functioning (10). The total scores for fatigue severity (3 items) and fatigue interference (6 items) range from 0 to 10, with higher scores indicating more severe fatigue.
The Brief Pain Inventory is a 11-item, 11-point measurement scale of pain severity and its interference with daily functioning (28) . The total scores for pain severity (4 items) and 
Statistical Analysis
Independent samples t-tests and Chi-square tests were conducted using SPSS 20 to compare the demographics and baseline characteristics of the two groups. Attrition analysis was performed to compare the profiles of the study dropouts (n = 9) and the completers (n = 130). Table 1 presents the demographic and clinical characteristics of the participants by treatment group. The mean age of the participants was 48.9 years (SD = 8.2) and they on average received 9.5 (SD = 8.2) days of radiotherapy sessions at the start of the study. The majority of the M A N U S C R I P T
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participants attained secondary educational level (65%), were married (63%), and had undergone breast conserving surgery (59%) and chemotherapy (80%). The two groups did not differ significantly in the demographic and clinical characteristics.
The descriptive statistics of outcome variables by treatment group are shown in Table 2 .
No significant difference (P > 0.05) was found in the outcome variables at pre-RT across the two groups. Comparisons on the profiles of the study dropouts (n = 9) and the completers (n = 130)
showed that at pre-RT the dropouts were significantly younger (M = 42. showed slight decreases in depression, fatigue severity, fatigue interference and quality of life but increases in perceived stress, pain severity, pain interference, and sleep disturbance.
Analysis of Treatment Effects
The unconditional growth models fitted the data well with insignificant χ 
Discussion
In the present study, latent growth modeling analyses demonstrated significant effects of DMT on stress, pain severity and pain interference compared to control condition. Consistent with previous findings (3-5), the control group showed an increase in perceived stress, pain severity, and pain interference over the course of RT. In contrast to Dibbell-Hope's study (18) , the only other RCT study that examined the effects of DMT on our outcomes, our study showed small but significant improvements in perceived stress for DMT over RT. The use of spontaneous The DMT group reported significant improvements in pain severity and pain interference over RT, with proportional improvements in comparison to the control group exceeding 25%.
These results resemble similar findings on the beneficial effects of body movement on pain among cancer patients receiving chemotherapy (36) . The body-oriented approach of DMT could improve range of arm motion and shoulder function, release muscular tension (13, 37), and promote patients' self-awareness of their own body. These might foster a greater internal focus of control and provide relief from the symptoms by shifting the focus away from the unpleasant and painful RT experiences (15) . These elements could contribute to effective pain control. Given the potential clinical value of DMT in pain reduction, DMT could be incorporated as part of an integrative cancer care treatment for prophylactic pain control at the onset of RT to facilitate early intervention.
Though Sandel and colleagues (19) reported a large treatment effect of DMT on quality of life, our DMT group showed no significant improvements on sleep disturbance and quality of
life. The lack of significant findings could be attributed to the short duration (3 weeks) between the pre and post assessments. Given the time constraint in relation to the radiotherapy treatment duration for the intervention, dramatic changes in quality of life were not expected. Consistent with Dibbell-Hope's study (18) , no significant effects were found for the DMT program in anxiety, depression, and fatigue in the present study. Interestingly, fatigue severity and interference decreased for both DMT and waitlist control groups over RT. Though such declines in fatigue stood in contrast with the expected worsening of fatigue during RT, previous studies (3, 38, 39) have reported a lessening of cancer-related fatigue.
In the present study, the majority of the participants had received chemotherapy before RT.
Fatigue associated with chemotherapy has been documented to be more intense than with RT (40) . Prior chemotherapy experience could shift in patients' standard in judging the symptom severity such that fatigue induced by RT was judged to be milder. Participants might plausibly feel less fatigued over time after the completion of chemotherapy. Smets et al. (41) noted that patients might gradually cope better with treatment-related demands such as daily trips to the clinic and meeting social obligations over the course of RT, making the patients feel less fatigued.
Besides, we did not ask the participants in the control group to refrain from engaging in symptom relief measures during the study. It is possible that participants in the control group might have performed exercise on their own during the study period, leading to a decrease in M A N U S C R I P T
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There were several study limitations. Since the study sample included only ambulatory patients, our findings cannot be generalized to those who are less mobile. Patients who were in severe fatigue or pain might lack the stamina or motivation to join the program. This may lead to sampling bias and response bias and underestimation of the severity of the symptoms in the sample. An interesting finding is that participants who dropped out of the study were significantly younger and displayed better sleep quality and quality of life. This may suggest that these participants were already accessing social support and the intervention was felt to be of less use to them. Future studies should explore the effects of DMT on patients who are more impaired by fatigue or pain.
Besides, the time constraint of RT treatment limited the duration of the intervention and the data collection interval. This might potentially hamper bigger changes to be observed in outcomes. Nevertheless, the DMT intervention had a high completion rate and was well received by most participants. No participants reported any adverse effects of DMT throughout the study.
The modest effect sizes of DMT found in this study could be explained by brevity of the intervention period. A prospective study with a longer DMT program that covers the post-treatment period and a longer follow-up period would elucidate the potential benefits and sustainability of DMT. Future studies should examine optimal treatment dose and duration for M A N U S C R I P T
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DMT interventions on cancer patients. 
Disclosures and Acknowledgments
